Prelude Therapeutics Incorporated
Patents, Design & Utilities
Last updated:
List of all Prelude Therapeutics Incorporated patents 26 in total
| Status | Patent |
|---|---|
Application | Utility: Selective Inhibitors Of Protein Arginine Methyltransferase 5 (PRMT5) Filling date: 7 Sep 2025 Issue date: 14 Jul 2022 |
Application | Utility: SELECTIVE INHIBITORS OF PROTEIN ARGININE METHYLTRANSFERASE 5 (PRMT5) Filling date: 7 Sep 2025 Issue date: 9 Jun 2022 |
Application | Utility: SELECTIVE INHIBITOR OF PROTEIN ARGININE METHYLTRANSFERASE 5 (PRMT5) Filling date: 7 Sep 2025 Issue date: 26 May 2022 |
Application | Utility: Selective Inhibitors Of Protein Arginine Methytransterase 5 (PRMT5) Filling date: 7 Sep 2025 Issue date: 19 May 2022 |
Application | Utility: Selective Inhibitors Of Protein Arginine Methyltransferase 5 (PRMT5) Filling date: 7 Sep 2025 Issue date: 19 May 2022 |
Application | Utility: CDK Inhibitors And Their Use As Pharmaceuticals Filling date: 7 Sep 2025 Issue date: 24 Mar 2022 |
Application | Utility: BICYCLIC HETEROCYCLIC DERIVATIVES AND THEIR USE AS PHARMACEUTICALS Filling date: 7 Sep 2025 Issue date: 3 Mar 2022 |
Grant | Utility: Selective inhibitors of protein arginine methyltransferase 5 (PRMT5) Filling date: 7 Sep 2025 Issue date: 22 Feb 2022 |
Application | Utility: BRM TARGETING COMPOUNDS AND ASSOCIATED METHODS OF USE Filling date: 7 Sep 2025 Issue date: 3 Feb 2022 |
Grant | Utility: Selective inhibitors of protein arginine methyltransferase 5 (PRMT5) Filling date: 7 Sep 2025 Issue date: 11 Jan 2022 |
Grant | Utility: Selective inhibitors of protein arginine methyltransferase 5 (PRMT5) Filling date: 7 Sep 2025 Issue date: 4 Jan 2022 |
Application | Utility: SELECTIVE INHIBITORS OF PROTEIN ARGININE METHYLTRANSFERASE 5 (PRMT5) Filling date: 7 Sep 2025 Issue date: 30 Dec 2021 |
Grant | Utility: Selective inhibitors of protein arginine methytransterase 5 (PRMT5) Filling date: 7 Sep 2025 Issue date: 28 Dec 2021 |
Application | Utility: BCL-2 INHIBITORS AND THEIR USE AS PHARMACEUTICALS Filling date: 7 Sep 2025 Issue date: 11 Nov 2021 |
Grant | Utility: Spiro-sulfonamide derivatives as inhibitors of myeloid cell leukemia-1 (MCL-1) protein Filling date: 7 Sep 2025 Issue date: 28 Sep 2021 |
Grant | Utility: Selective inhibitors of protein arginine methlytransferase 5 (PRMT5) Filling date: 7 Sep 2025 Issue date: 3 Aug 2021 |
Application | Utility: SELECTIVE INHIBITORS OF PROTEIN ARGININE METHYLTRANSFERASE 5 (PRMT5) Filling date: 7 Sep 2025 Issue date: 6 May 2021 |
Application | Utility: CDK INHIBITORS AND THEIR USE AS PHARMACEUTICALS Filling date: 7 Sep 2025 Issue date: 11 Mar 2021 |
Application | Utility: Selective Inhibitors Of Protein Arginine Methytransterase 5 (PRMT5) Filling date: 7 Sep 2025 Issue date: 19 Nov 2020 |
Application | Utility: SELECTIVE INHIBITORS OF PROTEIN ARGININE METHYLTRANSFERASE 5 (PRMT5) Filling date: 7 Sep 2025 Issue date: 19 Nov 2020 |
Application | Utility: SELECTIVE INHIBITORS OF PROTEIN ARGININE METHYLTRANSFERASE 5 (PRMT5) Filling date: 7 Sep 2025 Issue date: 17 Sep 2020 |
Grant | Utility: Selective inhibitors of protein arginine methyltransferase 5 (PRMT5) Filling date: 7 Sep 2025 Issue date: 14 Jul 2020 |
Application | Utility: Selective Inhibitors Of Protein Arginine Methytransterase 5 (PRMT5) Filling date: 7 Sep 2025 Issue date: 14 May 2020 |
Application | Utility: Spiro-Sulfonamide Derivatives As Inhibitors Of Myeloid Cell Leukemia-1 (MCL-1) Protein Filling date: 7 Sep 2025 Issue date: 14 May 2020 |
Grant | Utility: Selective inhibitors of protein arginine methyltransferase 5 (PRMT5) Filling date: 7 Sep 2025 Issue date: 25 Feb 2020 |
Application | Utility: SELECTIVE INHIBITORS OF PROTEIN ARGININE METHYLTRANSFERASE 5 (PRMT5) Filling date: 7 Sep 2025 Issue date: 19 Sep 2019 |
Showing 1 to 26 of 26 patents.